Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.

Proc Natl Acad Sci U S A 2005 Aug 8;102(33):11829-34. Epub 2005 Aug 8.

Department of Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

To create high-affinity antibodies, B cells target a high rate of somatic hypermutation (SHM) to the Ig variable-region genes that encode the antigen-binding site. This mutational process requires transcription and is triggered by activation-induced cytidine deaminase (AID), which converts deoxycytidine to deoxyuridine. Mistargeting of AID to non-Ig genes is thought to result in the malignant transformation of B cells, but the mechanism responsible for targeting SHM to certain DNA regions and not to others is largely unknown. Cis-acting elements have been proposed to play a role in directing the hypermutation machinery, but the motifs required for targeting SHM have been difficult to identify because many of the candidate elements, such as promoters or enhancers, are also required for transcription of Ig genes. Here we describe a system in cultured hybridoma cells in which transcription of the endogenous heavy-chain Ig gene continues in the absence of the core intronic enhancer (Emu) and its flanking matrix attachment regions (MARs). When AID is expressed in these cells, SHM occurred at the WT frequency even when Emu and the MARs were absent together. Interestingly, SHM occurred at less than the WT frequency when Emu or the MARs were individually absent. Our results suggest that these intronic regulatory elements can exert a complex influence on SHM that is separable from their role in regulating transcription.

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.0505449102
Publisher Site
http://dx.doi.org/10.1073/pnas.0505449102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1188009PMC
August 2005
5 Reads

Publication Analysis

Top Keywords

frequency emu
8
occurred frequency
8
shm occurred
8
hybridoma cells
8
somatic hypermutation
8
emu mars
8
targeting shm
8
shm
6
cells
5
continues absence
4
endogenous heavy-chain
4
mechanism responsible
4
malignant transformation
4
gene continues
4
transformation cells
4
heavy-chain gene
4
cells mechanism
4
absence core
4
deoxycytidine deoxyuridine
4
enhancer emu
4

Altmetric Statistics

References

(Supplied by CrossRef)

Li et al.
Genes & Development 2004

Shen et al.
International Immunology 2000

K  ppers et al.
Oncogene 2001

Pasqualucci et al.
Nature; Physical Science (London) 2001

Shen et al.
Science 1998

Journal of Experimental Medicine 2003

Bachl et al.
The Journal of Immunology 2001

Fukita et al.
Immunity 1998

Maizels et al.
Cell 1995

Rada et al.
The EMBO Journal 2001

Lebecque et al.
Journal of Experimental Medicine 1990

Similar Publications